Masters Pharmaceuticals Limited
Registered name: MASTERS PHARMACEUTICALS LIMITED
Masters Pharmaceuticals Limited made £30.7m revenue and £1.2m profit in the year to 31 Dec 2025.
Masters Pharmaceuticals Limited’s revenue grew 18% to £30.7m in the year to 31 Dec 2025, with £1.2m profit and 74 employees. The company is classified under “manufacture of pharmaceutical preparations” and is based in Elstree; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Elstree, East of England
- Age
- 42 yrs · since 1984
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | £26.1m | £26.1m | £30.7m |
| Cost of sales | −£18.7m | −£18.6m | −£21.7m |
| Gross profit | £7.4m | £7.4m | £8.9m |
| Operating profit | −£1m | £509k | £1.3m |
| Profit before tax | −£1.3m | £289k | £1.2m |
| Profit after tax | −£1.5m | £97k | £1.2m |
| Profit (best available) | −£1.5m | £97k | £1.2m |
| Employees (average) | 78 | 80 | 74 |
| Ratios | |||
| Profit margin | −5.6% | 0.4% | 3.8% |
| Gross margin | 28.4% | 28.5% | 29.1% |
| Revenue per employee | £335k | £326k | £415k |
| Profit per employee | −£18.9k | £1.2k | £15.7k |
| Growth (year on year) | |||
| Revenue growth | — | ▼0.3% | ▲17.8% |
| Profit growth | — | — | ▲1101% |
| Headcount growth | — | ▲2.6% | ▼7.5% |
| Balance sheet — indirect signals, not revenue | |||
| Net assets | — | — | — |
| Source | Accounts · bulk data Dec 2025 | Accounts · bulk data Dec 2025 | Accounts · bulk data Sep 2026 |
How the business works
- Profit margin
- 3.8%
- Profit ÷ revenue.
- Gross margin
- 29.1%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £415k
- Revenue ÷ average employees.
- Profit per employee
- £15.7k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- ▼8%
- Now 74
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Similar profitable businesses
- Brown & Burk UK LimitedHounslow · Manufacture of pharmaceutical preparations
- Revenue
- £36m
- Profit
- £2.6m
- Staff
- 20
- Vertical Pharma Resources LimitedWest Molesey · Manufacture of pharmaceutical preparations
- Revenue
- £39.2m
- Profit
- £5.3m
- Staff
- 89
- Morningside Healthcare LimitedNorthampton · Manufacture of pharmaceutical preparations
- Revenue
- £21.3m
- Profit
- £10.5m
- Staff
- 10
- Northumbria Pharma LtdSedgefield · Manufacture of pharmaceutical preparations
- Revenue
- £44.5m
- Profit
- £10.6k
- Staff
- 29
- Dermal Laboratories LimitedLoughton · Manufacture of pharmaceutical preparations
- Revenue
- £45.7m
- Profit
- £2.4m
- Staff
- 171
- Neon Healthcare LtdHertford · Manufacture of pharmaceutical preparations
- Revenue
- £51.2m
- Profit
- £1.7m
- Staff
- 21
Sources
Latest figures from accounts for the year to 31 Dec 2025 (profit £1.2m), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.
Updated from Companies House on 15 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.